thasso das glokalisierte Patientennetzwerk in theragenomischer und personalisierter Medizin und individualisierter Arzneimittelsicherheit

suchen: thasso

Search for:

Log in

Main Navigation

deutsch
- english
- français
- deutsch
- italiano
- español
- português
thasso
thasso: blog posts
communities
ressourcen
akademie
über uns
€ spenden
- thasso – danke

théragenomique: vidéos

Responsive WordPress Video Gallery Plugin

In/Out

Log in

Optional: Social Subscribe/Login

thasso: spenden

We need your help. Please support the development of thasso through donations. Thank you. Nous avons besoin de votre aide. S'il vous plaît, vous pouvez soutenir le développement de thasso grâce à des dons. Merci. Wir brauchen Ihre Hilfe. Bitte unterstützen Sie die Entwicklung von thasso durch Spenden. Vielen Dank. Abbiamo bisogno del tuo aiuto. Si prega di sostenere lo sviluppo di thasso attraverso donazioni. Grazie. Nós precisamos da sua ajuda. Por favor, apoie o desenvolvimento de thasso através de doações. Obrigada. Necesitamos tu ayuda. Por favor apoye el desarrollo de thasso con donaciones. Muchas gracias.

Donate Thasso

We need your help; Nous avons besoin de votre aide. Wir brauchen ihre Hilfe. Abbiamo bisogno del tuo aiuto. Necesitamos tu ayuda.Precisamos da sua ajuda.

thasso: zustände

thasso: neueste tweets

https://twitter.com/thasso_info

Swissmedic: Aktualitäten

Swissmedic lässt Impfstoff zur Bekämpfung der Blauzungenkrankheit des Serotyp 3 zu ... July 9, 2025

BfArM: presse mitteilungen

Keine Hinweise auf "Opioid-Krise" in Deutschland: Verordnung von opioidhaltigen Schmerzmitteln ist rückläufig March 10, 2025
BfArM erweitert öffentlichen Zugang zu Arzneimittel- und Zulassungsdaten January 28, 2025
Arzneimittelklassifikation: BfArM veröffentlicht amtliche Fassung der ATC-Klassifikation mit definierten Tagesdosen December 17, 2024
Zentraler Terminologieserver verbessert den Austausch von Gesundheitsdaten December 4, 2024
#MedSafetyWeek 2024: Internationale Kampagne zur Meldung von Nebenwirkungen October 30, 2024

AGES: mitteilungen

Rückruf: SPAR LEBENSQUELL 1 l STILL July 8, 2025
Rückruf: TEDi Trinkglas 3er Set July 4, 2025
Rückruf: SENZATE NAGELLACKENTFERNER OHNE ACETON 200ML July 3, 2025
Rückruf: Squishy Toys July 1, 2025
Warnung: Plüschbär June 27, 2025

zufällige genetik

Chromosomal abnormality scores unlock path to personalized immunotherapy July 9, 2025
In a newly published article in Nature Genetics, researchers from the University of Chicago have identified tumor aneuploidy—an imbalance in the number of chromosomes—as a powerful biomarker associated with resistance to immunotherapy across cancer types. The study emphasizes how combining immunotherapy with radiation may help overcome the issue of therapy resistance, offering a new framework […]
New method traces cancer cell evolution from a single tissue sample July 9, 2025
Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the formation of a malignant tumor.
A 'Google Maps' for tau movement sheds light on why some brain regions resist Alzheimer's July 9, 2025
It's been recognized for some time that Alzheimer's disease affects brain regions differently and that tau—a protein known to misbehave—plays an important role in the disease. Normally, tau helps stabilize neurons, but in Alzheimer's disease, it begins to misfold and tangle inside neurons. It spreads across the brain forming toxic clumps that impair neuronal function […]
Cellular signature explains why some prostate tumors resist standard treatments July 9, 2025
A new study by University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment.
Genome editing enables mice to produce their own weight-loss drug for months July 9, 2025
Weight-loss drugs have surged in popularity, promising rapid results with regular injections. Now, researchers from Japan report a way for the body to make its own weight-loss drugs, doing away with injections in favor of a one-time treatment.

kürzliche kommentare

Joseph Gut - thasso on Alzheimer’s: Are we at the beginning of a new era of treatment?: “Finally, Leqembi has now also been approved by the EMA. See https://www.ema.europa.eu/en/medicines/human/EPAR/leqembi#product-info” Jun 23, 08:12
20urbain05 on Orofacial clefts: Can genetic variants reveal how they arise?: “It would be of particular interest, which of the many existing sequence variants of the DDX1 gene is (are) particularly…” Apr 19, 13:33
20justin03 on Molecular differences in pancreatic cancer of patients with Caucasian or African Ethnicity: “Some new knowledge on the aggressivity of pancreatic cancer. Not yet known if this mechanism is more active in some…” Apr 17, 15:43
Joseph Gut - thasso on Semagludite: The cause for NAION and Blood Clots?: “NAION is slowly developing into a case for legal actions, according to Tom Lamb at Drug Injury Watch. https://www.drug-injury.com” Apr 10, 13:48
Joseph Gut - thasso on Molecular differences in pancreatic cancer of patients with Caucasian or African Ethnicity: “Newest research: New hope for patients with pancreatic cancer? https://medicalxpress.com/news/2025-04-proof-concept-approach-pancreatic-cancer.html” Apr 9, 14:02

Footer Menu

deutsch
thasso
thasso: blog posts
communities
ressourcen
akademie
über uns
€ spenden